Up And Up Arthritis Pain Reliever Gel
Product Images NDC 11673-569

15 FDA label images from Target Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Up And Up Arthritis Pain Reliever (NDC 11673-569). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Target Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (Image 1)

Image 1 (Image 1)
An instructional illustration showing a pair of hands opening a box and removing a blister card or strip containing individual medication doses. The image demonstrates how to take the product from its packaging.*
FDA Label Image

Image 2 (Image 01)

Image 2 (Image 01)
up & up arthritis pain reliever diclofenac sodium topical gel 1%, 150 g tube label. The orange and white label states it is for arthritis pain relief, anti-inflammatory, and external use only. It compares to Voltaren Arthritis Pain and shows dosing instructions with an enclosed card. Treatment areas include hand, wrist, elbow, foot, ankle, and knee. Labeler is Target Corporation.*
FDA Label Image

Image 3 (Image 02)

Image 3 (Image 02)
Drug Facts for up and up arthritis pain reliever 10 mg/g gel with active ingredient diclofenac sodium 1%. The panel covers active ingredients, uses for temporary arthritis pain relief, warnings including allergy risk, liver and stomach warnings, usage directions, storage instructions, and additional safety information. The label advises using the enclosed dosing card and contains a customer support phone number.*
FDA Label Image

Image 4 (Image 03)

Image 4 (Image 03)
An instructional diagram showing correct and incorrect application areas for up and up arthritis pain reliever gel. It illustrates proper use on two areas (hand and knee; knees only) and one area (knee). Incorrect use is shown applying the gel to three areas (hands and ankle).*
FDA Label Image

Image 5 (Image 04)

Image 5 (Image 04)
An instructional illustration depicts a hand squeezing gel from a tube labeled with active ingredient "Diclofenac Sodium" onto a dosing card. The dosing card is marked for a lower body dose of 4.5 inches long (4 grams), providing a visual guide for topical gel application.*
FDA Label Image

Image 6 (Image 05)

Image 6 (Image 05)
An instructional diagram depicting a gel tube labeled 'Diclofenac Sodium Topical Gel, 1%' with a dosing card attached to demonstrate the amount of gel recommended for application. The illustrated dose shown is for upper body areas, approximately 2.25 inches long (2 grams), guiding proper topical use of the arthritis pain reliever gel by Target Corporation.*
FDA Label Image

Image 7 (Image 06)

Image 7 (Image 06)
An instructional illustration showing the application areas for up and up arthritis pain reliever gel on the body. It depicts upper body areas including elbow, wrist, and hand, and lower body areas including knee, ankle, and foot, with guidance to apply on various sides and parts of each joint and limb section.*
FDA Label Image

Image 8 (Image 07)

Image 8 (Image 07)
An instructional illustration showing hands under running water from a faucet, demonstrating hand washing or rinsing. The image features water droplets falling onto the hands held together under the stream.*
FDA Label Image

Image 9 (Image 08)

Image 9 (Image 08)
An instructional line drawing showing hands holding a tube labeled "up and up arthritis pain reliever 10 mg/g" under running water from a faucet, demonstrating rinsing or washing instructions for use with this topical gel product.*
FDA Label Image

Image 10 (Image 09)

Image 10 (Image 09)
An illustration of a clock face showing the number 10 in the center with the text 'minutes' below it, representing a 10-minute time interval highlighted on the clock.*
FDA Label Image

Image 11 (Image 10)

Image 11 (Image 10)
An anatomical illustration showing two joint cross-sections. One depicts healthy cartilage with smooth surfaces, and the other shows worn-away cartilage with broken areas, illustrating joint cartilage deterioration.*
FDA Label Image

Image 12 (Image 11)

Image 12 (Image 11)
Instructional illustrations showing the targeted application areas for up and up arthritis pain reliever gel. The four sections indicate the hand and elbow for the upper body, knee and ankle for the lower body, wrist and ankle for combined upper and lower body, and left and right knees separately for lower body application. Each area is marked with a star to denote the typical site.*
FDA Label Image

Artritis-pain-reliever-image-1 (87a5fuwc3 Image 1)

Artritis-pain-reliever-image-1 (87a5fuwc3 Image 1)
Packaging label for up and up Arthritis Pain Reliever 1% diclofenac sodium topical gel, an NSAID gel for topical use. The orange box displays the product name, active ingredient, and strength prominently. It includes treatment area icons for hand/wrist, elbow, foot/ankle, and knee. The net weight is 5.29 oz (150 g), and the labeler is Target Corporation. A barcode and tamper-evident statement are also visible.*
FDA Label Image

Artritis-pain-reliever-image-2 (87a5fuwc3 Image 2)

Artritis-pain-reliever-image-2 (87a5fuwc3 Image 2)
The packaging label for up and up arthritis pain reliever diclofenac sodium topical gel, 1% (10 mg/g) shows dosing instructions with an enclosed dosing card indicating upper and lower body dose measurements. It includes use directions, cautionary details, and highlights the product as an OTC topical gel by Target Corporation. The label also states distribution by Target Corporation, made in Israel.*
FDA Label Image

Artritis-pain-reliever-image-3 (87a5fuwc3 Image 3)

Artritis-pain-reliever-image-3 (87a5fuwc3 Image 3)
Drug Facts panel continuing warnings and precautions for up and up arthritis pain reliever gel, diclofenac sodium 10 mg/g topical. It advises when to ask a doctor before use, when to stop use and ask a doctor, and specific warnings about side effects, symptoms requiring medical advice, and use during pregnancy or breastfeeding. It includes instructions for eye contact and child safety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.